A life-course model for healthier ageing: lessons learned during the COVID-19 pandemic [0.03%]
新冠肺炎疫情期间总结的健康老龄化生活阶段模式的经验教训
Ashley Jowell,Laura L Carstensen,Michele Barry
Ashley Jowell
Muhammad Yunus,Cam Donaldson,Jean-Luc Perron
Muhammad Yunus
Erin Hulland
Erin Hulland
The Lancet Healthy Longevity
The Lancet Healthy Longevity
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study [0.03%]
基线抗体状况不同的工作人员和居民的SARS-CoV-2感染发病情况：对100家长期护理机构的研究（VIVALDI）：一项前瞻性队列研究
Maria Krutikov,Tom Palmer,Gokhan Tut et al.
Maria Krutikov et al.
Background: SARS-CoV-2 infection represents a major challenge for long-term care facilities (LTCFs) and many residents and staff are seropositive following persistent outbreaks. We aimed to investigate the association bet...
Melissa K Andrew,Lisa Barrett
Melissa K Andrew
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study [0.03%]
竞争性死亡风险对QRISK3心血管风险预测工具在老年人和合并症患者中预测性能的影响：外部验证队列研究
Shona Livingstone,Daniel R Morales,Peter T Donnan et al.
Shona Livingstone et al.
Background: Primary prevention of cardiovascular disease (CVD) is guided by risk-prediction tools, but these rarely account for the risk of dying from other conditions (ie, competing mortality risk). In England and Wales,...
Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials [0.03%]
靶向衰老的生物学以改善老年人免疫功能：mTOR抑制剂2b期和3期随机试验
Joan B Mannick,Grace Teo,Patti Bernardo et al.
Joan B Mannick et al.
Background: The COVID-19 pandemic highlights the need for therapies that improve immune function in older adults, including interferon (IFN)-induced antiviral immunity that declines with age. In a previous phase 2a trial,...
COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective [0.03%]
老年癌症患者的Covid-19疫苗接种：青年老年肿瘤学会的观点
Kah Poh Loh,Enrique Soto-Perez-de-Celis,Anna Rachelle Mislang et al.
Kah Poh Loh et al.
Clinical trials of mTOR inhibitors to boost immunity to viral infection in older adults [0.03%]
临床试验：mTOR抑制剂可通过提高老年人对病毒感染的免疫反应来延年益寿
Paula Juricic Dzankic,Linda Partridge
Paula Juricic Dzankic